SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-001378
Filing Date
2020-05-04
Accepted
2020-05-01 21:00:15
Documents
4
Period of Report
2020-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gala_8k-042920.htm 8-K 20010
2 RESIGNATION OF R. MARTINEZ gala_ex1701.htm EX-17.1 3076
3 RESIGNATION OF G. CICHY gala_ex1702.htm EX-17.2 2783
4 RESIGNATION OF M. CHEUNG gala_ex1703.htm EX-17.3 3167
  Complete submission text file 0001683168-20-001378.txt   30634
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceutical Inc. (Filer) CIK: 0001513403 (see all company filings)

IRS No.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 000-55998 | Film No.: 20842455
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl